Teva Pharmaceutical Industries Limited (TEVA)

Trade TEVA now with
5/2/2019 7:04:58 AM Teva Q1 Non-GAAP EPS $0.60; GAAP Loss Per Share $0.10
4/23/2019 9:09:48 AM Compass Minerals Names Kevin Crutchfield President And CEO
4/23/2019 9:07:54 AM Teva Discontinues Clinical Development Program For Use Of Fremanezumab In Cluster Headaches
4/10/2019 8:11:36 AM Teva Enters New $2.3 Bln Unsecured Revolving Credit Facility
4/1/2019 8:30:39 AM Teva: AJOVY Gets EU Approval Offering Patients First, Only Anti-CGRP Treatment
3/18/2019 7:05:34 AM Novo Nordisk Settles US Patent Litigation Case On Victoza With Teva
2/13/2019 7:04:29 AM Teva Q4 Non-GAAP EPS $0.53, GAAP Loss Per Share $2.85
2/6/2019 11:26:15 AM Teva Announces U.S. Launch Of A Generic Version Of Sabril
2/5/2019 7:37:01 PM Teva Announces Launch Of ALYQ, Generic Version Of ADCIRCA In U.S.
2/1/2019 6:54:32 AM Teva Receives Positive CHMP Opinion For AJOVY For Prophylaxis Of Migraine In Adults